China Universal Asset Management Company’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
TDC
RS
AHL
NC
QC
CAL
China Universal Asset Management Company's RCEL Position: Q2 2026 in Review
China Universal Asset Management Company increased its Avita Medical (RCEL) stake by 25% in Q2 2026, buying an estimated $10.8K and bringing the position to 12,500 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #459.
China Universal Asset Management Company first reported a position in RCEL in Q4 2025 and has held it in 3 quarters since. 24 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.
- China Universal Asset Management Company held 12,500 shares of Avita Medical worth $51.6K as of Q2 2026.
- China Universal Asset Management Company bought 2,500 Avita Medical shares in Q2 2026, an estimated $10.8K.
- Avita Medical made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #459 holding.
- China Universal Asset Management Company first reported a position in Avita Medical in Q4 2025 and has held it in 3 quarters since.
- 24 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.